Trials / Withdrawn
WithdrawnNCT04240587
Intranasal Neurostimulation for the Treatment of Neurosensory Abnormalities in CL Wearers (INTAC)
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Tufts Medical Center · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
To find out if the use of an intranasal tear neurostimulator (ITN), may be useful in decreasing the pain symptoms felt by patients who experience contact lens discomfort.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TrueTear™ intranasal neurostimulator (ITN) | The ITN delivers small electrical currents to the inner cavity of the nose, gently activating nerves that stimulate the body's natural tear production system. Those in the ITN "active" arm will receive the active tips which contain the current from the base to the nasociliary nerve. Those in the ITN "sham" arm will receive tips without the current. |
Timeline
- Start date
- 2020-03-23
- Primary completion
- 2021-11-03
- Completion
- 2021-11-03
- First posted
- 2020-01-27
- Last updated
- 2021-11-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04240587. Inclusion in this directory is not an endorsement.